{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:21:14Z","timestamp":1793816474248,"version":"4.6.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007374","name":"Universidade Federal de Minas Gerais","doi-asserted-by":"publisher","award":["FUNDEP 01\/2022"],"award-info":[{"award-number":["FUNDEP 01\/2022"]}],"id":[{"id":"10.13039\/501100007374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["RED-00081-23"],"award-info":[{"award-number":["RED-00081-23"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["RED-00202- 22"],"award-info":[{"award-number":["RED-00202- 22"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["TEC-RED-00282-16"],"award-info":[{"award-number":["TEC-RED-00282-16"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["406097\/2021-6"],"award-info":[{"award-number":["406097\/2021-6"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.peptides.2024.171182","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T05:57:34Z","timestamp":1709099854000},"page":"171182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The Mas agonist CGEN-856S prevents Ang II induced cardiomyocyte hypertrophy via nitric oxide production"],"prefix":"10.1016","volume":"175","author":[{"given":"Eduardo","family":"Nocchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio","family":"Scalzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cibele","family":"Rocha-Resende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Parreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiany","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robson A.S.","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Guatimosim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2024.171182_bib1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/1753944716642677","article-title":"Cardiac remodelling and RAS inhibition","volume":"10","author":"Ferrario","year":"2016","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"10.1016\/j.peptides.2024.171182_bib2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","article-title":"Counter-regulatory renin\u2013angiotensin system in cardiovascular disease","volume":"17","author":"Paz Ocaranza","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.peptides.2024.171182_bib3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1590\/S0100-879X2005000400003","article-title":"Cardiovascular actions of angiotensin-(1-7)","volume":"38","author":"Ferreira","year":"2005","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.peptides.2024.171182_bib4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0196-9781(93)90097-Z","article-title":"Cardiovascular actions of angiotensin(1\u20137)","volume":"14","author":"Benter","year":"1993","journal-title":"Peptides (N.Y.)"},{"key":"10.1016\/j.peptides.2024.171182_bib5","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/01.HYP.26.6.1138","article-title":"Pressor and reflex sensitivity is altered in spontaneously hypertensive rats treated with angiotensin-(1-7)","volume":"26","author":"Benter","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2024.171182_bib6","doi-asserted-by":"crossref","first-page":"H324","DOI":"10.1152\/ajpheart.1989.257.1.H324","article-title":"Cardiovascular effects of angiotensin-(1-7) injected into the dorsal medulla of rats","volume":"257","author":"Campagnole-Santos","year":"1989","journal-title":"Am. J. Physiol. -Heart Circ. Physiol."},{"key":"10.1016\/j.peptides.2024.171182_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/493129","article-title":"Angiotensin-(1-7)-mediated signaling in cardiomyocytes","volume":"2012","author":"Gomes","year":"2012","journal-title":"Int. J. Hypertens."},{"key":"10.1016\/j.peptides.2024.171182_bib8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/HYPERTENSIONAHA.108.114280","article-title":"Molecular mechanisms involved in the angiotensin-(1-7)\/mas signaling pathway in cardiomyocytes","volume":"52","author":"Dias-Peixoto","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2024.171182_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1161\/HYPERTENSIONAHA.109.143255","article-title":"Angiotensin-(1-7) prevents cardiomyocyte pathological remodeling through a nitric oxide\/guanosine 3\u2032,5\u2032-cyclic monophosphate\u2013dependent pathway","volume":"55","author":"Gomes","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2024.171182_bib10","doi-asserted-by":"crossref","first-page":"34643","DOI":"10.1074\/jbc.M805181200","article-title":"Discovery and validation of novel peptide agonists for G-protein-coupled receptors","volume":"283","author":"Shemesh","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2024.171182_bib11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1161\/HYPERTENSIONAHA.110.152942","article-title":"Vascular relaxation, antihypertensive effect, and cardioprotection of a novel peptide agonist of the mas receptor","volume":"56","author":"Savergnini","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2024.171182_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057757","article-title":"The Novel Mas agonist, CGEN-856S, attenuates isoproterenol-induced cardiac remodeling and myocardial infarction injury in rats","volume":"8","author":"Savergnini","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2024.171182_bib13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1113\/expphysiol.2008.042002","article-title":"Recent advances in the angiotensin-converting enzyme 2\u2013angiotensin(1\u20137)\u2013Mas axis","volume":"93","author":"Santos","year":"2008","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.peptides.2024.171182_bib14","doi-asserted-by":"crossref","first-page":"11867","DOI":"10.1074\/jbc.273.19.11867","article-title":"Sustained long term potentiation and anxiety in mice lacking themas protooncogene","volume":"273","author":"Walther","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2024.171182_bib15","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1152\/ajpcell.2001.280.5.C1327","article-title":"Molecular, Molecular identification of a TTX-sensitive Ca(2+) current","volume":"21201","author":"Guatimosim","year":"2001","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.peptides.2024.171182_bib16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ceca.2007.11.016","article-title":"Nuclear Ca2+ regulates cardiomyocyte function","volume":"44","author":"Guatimosim","year":"2008","journal-title":"Cell Calcium"},{"key":"10.1016\/j.peptides.2024.171182_bib17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/HYPERTENSIONAHA.110.167346","article-title":"An oral formulation of angiotensin-(1-7) produces cardioprotective effects in infarcted and isoproterenol-treated rats","volume":"57","author":"Marques","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2024.171182_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/01.HYP.0000251865.35728.2f","article-title":"Angiotensin-(1-7) through receptor mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways","volume":"49","author":"Sampaio","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2024.171182_bib19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/01.RES.73.3.413","article-title":"Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype","volume":"73","author":"Sadoshima","year":"1993","journal-title":"Circ. Res"},{"key":"10.1016\/j.peptides.2024.171182_bib20","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/CIRCRESAHA.116.304475","article-title":"GRK5-mediated exacerbation of pathological cardiac hypertrophy involves facilitation of nuclear NFAT activity","volume":"115","author":"Hullmann","year":"2014","journal-title":"Circ. Res"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978124000354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978124000354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:40:11Z","timestamp":1777527611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978124000354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":20,"alternative-id":["S0196978124000354"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2024.171182","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Mas agonist CGEN-856S prevents Ang II induced cardiomyocyte hypertrophy via nitric oxide production","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2024.171182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"171182"}}